drugset / Trial / NCT00986362
Clinical Trial of Intravitreal Microplasmin in Infants and Children Scheduled for Vitrectomy
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate the safety and preliminary efficacy of intravitreal microplasmin as an adjunct to conventional vitrectomy for the treatment of pediatric patients.
Timeline
- Start
- 2010-02
- Primary completion
- 2011-12
- Completion
- 2012-04
Outcome
Missed primary endpoint
registry Ocriplasmin vs Placebo; p = 0.679; Odds Ratio (OR) 0.613 (95% CI 0.070 to 4.509); Fisher Exact NCT00986362 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ocriplasmin | Protein / enzyme biologic | 175 ug | Intravitreal |
Indications
No indication recorded.